Publication:
Long-term outcomes of living-related kidney donation for alport syndrome spectrum: a propensity score-matched analysis

dc.contributor.coauthorOto, Ozgur Akin
dc.contributor.coauthorSafak, Seda
dc.contributor.coauthorMirioglu, Safak
dc.contributor.coauthorVelioglu, Arzu
dc.contributor.coauthorDirim, Ahmet Burak
dc.contributor.coauthorGuller, Nurana
dc.contributor.coauthorYildiz, Abdulmecit
dc.contributor.coauthorErsoy, Alparslan
dc.contributor.coauthorTurkmen, Aydin
dc.contributor.coauthorYazici, Halil
dc.contributor.coauthorLentine, Krista L. L.
dc.contributor.coauthorCaliskan, Yasar
dc.contributor.kuauthorYelken, Berna
dc.contributor.kuprofileDoctor
dc.contributor.unitKoç University Hospital
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T23:45:15Z
dc.date.issued2022
dc.description.abstractIntroduction: Data to guide the evaluation of living-related donor candidates for kidney transplant recipients with Alport syndrome (AS) spectrum are limited. We aimed to examine a cohort of living-related donors to recipients with AS and compare their outcomes with a control group to improve understanding of the clinical course and outcomes of living donation in this context. Methods: Living donors (LDs) of AS recipients and propensity score-matched control LDs without any family history of AS (control group) were followed for major cardiac events, death, post-donation estimated glomerular filtration rate (eGFR), and proteinuria. Results: There were 31 LDs (48.4% male), in whom relationship to AS recipient included mother (45.2%), father (32.3%), sibling (16.1%), grandparent (3.2%), and uncle (3.2%). Long-term outcomes over 10.0 (IQR, 3.0-15.0) years were evaluated in 25 and 25 LDs from study and control groups, respectively. During follow-up, 5 LDs (20.0%) in study group developed major cardiac event (acute coronary ischemia [n = 4] and severe congestive heart failure [n = 1]) after 5.5 (IQR, 4.5-10.3) years, whereas only 2 (8.0%) LDs in control group developed major cardiac events (p = 0.221). New-onset hypertension was higher in study group (56.0%) compared to the control group (16.0%) (p = 0.003). Three donors in study and 2 donors in control group who developed new-onset hypertension died during follow-up (p = 0.297). Major cardiac event rate was significantly higher in donors who developed hypertension after donation (0 vs. 28.0%, p < 0.001). There were no differences between study groups regarding last eGFR and proteinuria levels (p = 0.558 and p = 0.120, respectively). Discussion/Conclusion: Although the risk of kidney disease can be minimized by careful donor evaluation, our findings suggest that hypertension risk after the donation is higher than expected in related donors of recipients with AS.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue45177
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.volume53
dc.identifier.doi10.1159/000527180
dc.identifier.eissn1421-9670
dc.identifier.issn0250-8095
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85143199217
dc.identifier.urihttp://dx.doi.org/10.1159/000527180
dc.identifier.urihttps://hdl.handle.net/20.500.14288/13799
dc.identifier.wos882633200001
dc.keywordsAlport syndrome
dc.keywordsCardiovascular outcomes
dc.keywordsCollagen
dc.keywordsGenetics
dc.keywordsKidney transplantation
dc.keywordsLiving donors joint consensus recommendation
dc.keywordsRenal-transplant
dc.keywordsMedical genetics
dc.keywordsAmerican-college
dc.keywordsGuidelines
dc.keywordsStandards
dc.keywordsVariants
dc.keywordsGenotype
dc.keywordsGenomics
dc.keywordsRamipril
dc.languageEnglish
dc.publisherKarger Publishers
dc.sourceAmerican Journal of Nephrology
dc.subjectUrology
dc.subjectNephrology
dc.titleLong-term outcomes of living-related kidney donation for alport syndrome spectrum: a propensity score-matched analysis
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0003-2244-9629
local.contributor.kuauthorYelken, Berna

Files